Literature DB >> 2081261

Cimetidine use and gastric cancer.

M C Schumacher1, S S Jick, H Jick, A D Feld.   

Abstract

We conducted a case-control study at Group Health Cooperative of Puget Sound to investigate the relation between long-term cimetidine use and gastric cancer. Five of 99 cases of gastric cancer were exposed to cimetidine at least two years before diagnosis, whereas nine of 365 controls (selected from among users of the Group Health Cooperative pharmacy, matched on age, sex, and first year of pharmacy use) were similarly exposed. The odds ratio comparing users with nonusers was 2.3 (95% CI = 0.8-6.9). The odds ratio comparing users of antacids with nonusers was similar, 1.9 (95% CI = 1.0-3.7). Although a causal relation between gastric cancer and cimetidine is possible, the similarity of the findings for cimetidine and antacids lends support to other explanations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2081261     DOI: 10.1097/00001648-199005000-00012

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  9 in total

1.  Partial gastrectomy and subsequent gastric cancer risk.

Authors:  C La Vecchia; E Negri; B D'Avanzo; H Moller; S Franceschi
Journal:  J Epidemiol Community Health       Date:  1992-02       Impact factor: 3.710

Review 2.  Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Authors:  Jeong Soo Ahn; Chun-Sick Eom; Christie Y Jeon; Sang Min Park
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

Review 3.  Formulary management of drugs for cancer-associated hypercalcaemia.

Authors:  S J Gallacher
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

4.  Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluation.

Authors:  R F Tasch; R Goeree; C J Henke; B J O'Brien
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

5.  Habit, prejudice, power and politics: issues in the conversion of H2-receptor antagonists to over-the-counter use.

Authors:  R H Hunt
Journal:  CMAJ       Date:  1996-01-01       Impact factor: 8.262

6.  Gastric cancer risk after vagotomy.

Authors:  G Lundegårdh; A Ekbom; J K McLaughlin; O Nyrén
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

7.  Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users.

Authors:  H Møller; A Nissen; J Mosbech
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

Review 8.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 9.  Vagotomy and Gastric Tumorigenesis.

Authors:  Hanne-Line Rabben; Chun-Mei Zhao; Yoku Hayakawa; Timothy C Wang; Duan Chen
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.